Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of sintilimab plus chemotherapy for advanced or metastatic esophageal squamous cell carcinoma.
You, Maojin; Huang, Yufan; Cai, Zhongjie; Wu, Qingfeng; Zhu, Wei; He, Ying; Chen, Ruijia.
Affiliation
  • You M; Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
  • Huang Y; Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
  • Cai Z; Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
  • Wu Q; Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
  • Zhu W; Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
  • He Y; Department of Emergency Medicine, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
  • Chen R; Department of Pharmacy, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Front Oncol ; 12: 986762, 2022.
Article in En | MEDLINE | ID: mdl-36568254
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China